Devalingam Mahalingam, MD, PhD
Northwestern Medical GroupPrimary Specialty
Hematology and Medical Oncology
Is your insurance accepted? Select plan
Accepts your insurance
Does not accept your insurance
Based on January 2026 plan details.
Accepted plans are subject to change. To be sure this medical professional is covered by your insurance plan, please contact your insurance carrier.
Practice Focus Areas
This medical professional has a particular interest or expertise in:
Education
- Medical Education:
-
MD, National University of Ireland Galway - 2000
- Fellowships:
-
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine - 2009
Languages Spoken
- Malay
Board Certifications
- American Board of Internal Medicine - Internal Medicine (Certified)
- American Board of Internal Medicine/Medical Oncology - Medical Oncology (Certified)
Faculty Profile
Professor, Feinberg School of MedicinePractice Groups and Affiliations
- Medical Group:
- Northwestern Medical Group
- On Medical Staff At:
-
Northwestern Memorial Hospital
Ratings and Reviews
At Northwestern Medicine, our patient’s feedback is important to us. While different care providers have their own unique strengths, we strive to be as transparent as possible with our quality of care.
Read Ratings FAQsOverall Rating
768 Ratings
Reviews from Patients
Reviews from Patients
August 10, 2026
5.0 star star star star starDr. Mahalingam was excellent. Extremely well versed in my husband's extensive and complicated medical history. Very informative in regards to the clinical trial we were there to discuss. Answered all of our questions in a straight forward manner that was easy to understand.
August 10, 2026
5.0 star star star star starDr. Mahalingam is simply the best! Not only is he a skilled and excellent physician, but he also has a kind and reassuring demeanor that helps put the patient's mind at ease. He takes the time to clearly and carefully explain the nature of the cancer and the treatment plan to the patient and patiently listens and responds to their questions and concerns.
August 03, 2026
5.0 star star star star starAgain, Dr. Mahalingam, throughout the entire past year of Immunotherapy treatment for my mother, has been an extremely caring, concerned, gifted and talented oncologist, who was incredibly present and communicative throughout the whole year of treatment. I would highly recommend Dr. Mahalingam as an oncologist.
May 19, 2026
4.0 star star star star star_borderI have had this doctor for less than a year. So far, I am happy with him. For the period of time before that I had Dr [last name], was very happy with him. Dr Mahalingam has been prompt in answering my questions and explaining my treatment.
Disclosures
Industry Relationships
Consulting
Faculty member and/or their immediate family have engaged in activities such as speaking, advising, consulting, or providing educational programs for the following companies or other entities
- Actuate Therapeutics, Inc.
- Bristol-Myers Squibb Company
- Exelixis, Inc.
- Oncolytics Biotech Inc
- Qurient Co. Ltd.
External Professional Relationships
Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.